Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Genetic Medicine Research, |
RCV000228691 | SCV000265825 | uncertain significance | not specified | 2015-12-01 | criteria provided, single submitter | research | |
Gene |
RCV001596986 | SCV001830852 | uncertain significance | not provided | 2019-12-03 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Reported previously in the heterozygous state as a variant of uncertain significance, along with a NEB variant of uncertain significance, in a patient with congenital muscular dystrophy (Punetha et al., 2016); This variant is associated with the following publications: (PMID: 27854218) |
Athena Diagnostics | RCV000228691 | SCV001880388 | likely benign | not specified | 2021-04-28 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000228691 | SCV002068523 | uncertain significance | not specified | 2017-08-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002057057 | SCV002408888 | benign | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2; Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2; Autosomal recessive limb-girdle muscular dystrophy type 2N | 2024-01-21 | criteria provided, single submitter | clinical testing |